Non-invAsive VentIlation for early General wArd respiraTory failurE (NAVIGATE): A multicenter randomized controlled study. Protocol and statistical analysis plan

Contemp Clin Trials. 2019 Mar:78:126-132. doi: 10.1016/j.cct.2019.02.001. Epub 2019 Feb 7.

Abstract

Objective: Few randomized trials have evaluated the use of non-invasive ventilation (NIV) for early acute respiratory failure (ARF) in non-intensive care unit (ICU) wards. The aim of this study is to test the hypothesis that early NIV for mild-moderate ARF in non-ICU wards can prevent development of severe ARF.

Design: Pragmatic, parallel group, randomized, controlled, multicenter trial.

Setting: Non-intensive care wards of tertiary centers.

Patients: Non-ICU ward patients with mild to moderate ARF without an established indication for NIV.

Interventions: Patients will be randomized to receive or not receive NIV in addition to best available care.

Measurements and main results: We will enroll 520 patients, 260 in each group. The primary endpoint of the study will be the development of severe ARF. Secondary endpoints will be 28-day mortality, length of hospital stay, safety of NIV in non-ICU environments, and a composite endpoint of all in-hospital respiratory complications.

Conclusions: This trial will help determine whether the early use of NIV in non-ICU wards can prevent progression from mild-moderate ARF to severe ARF.

Trial registration: ClinicalTrials.gov NCT01572337.

Keywords: ARF; Acute respiratory failure; NIV; Non-invasive ventilation.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Comorbidity
  • Disease Progression
  • Female
  • Hospital Mortality
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Noninvasive Ventilation* / methods
  • Pragmatic Clinical Trials as Topic
  • Research Design
  • Respiratory Insufficiency* / therapy
  • Sex Factors
  • Tertiary Care Centers
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT01572337